Sage Therapeutics Is A Biopharmaceutical Company Based In Cambridgemassachusettsdedicated To Developing Innovative Treatments For Central Nervous Systemcnsdisordersfounded In 2010Sage Has Become A Leader In Maternal Mental Healthparticularly With Its Fda Approved Therapies For Postpartum Depressionppdthe Company Offers Zulressobrexanolone The First Intravenous Treatment For Ppdand Zurzuvaezuranolone An Oral Medication Approved In 2023Sage Is Also Advancing A Pipeline Of Investigational Therapies Targeting Major Depressive Disorderessential Tremorand Neurodevelopmental Disorderscollaborations With Organizations Like Biogen And Shionogi Support Its Development And Commercialization Effortssage Therapeutics Emphasizes Patient And Caregiver Perspectives In Its Drug Development Processaiming To Improve Accessibility For Those Affected By Cns Conditions
United States
